Microalbuminuria and C-reactive protein: Similar messengers of cardiovascular risk?

被引:21
作者
Bakker, SJL [1 ]
Gansevoort, RT [1 ]
Stuveling, EM [1 ]
Gans, ROB [1 ]
de Zeeuw, D [1 ]
机构
[1] Univ Groningen, Med Ctr, Dept Internal Med, NL-9713 GZ Groningen, Netherlands
关键词
D O I
10.1007/s11906-005-0075-3
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
C-reactive protein (CRP) and urinary albumin excretion are both determinants of cardiovascular risk. The first is closely related to systemic and vascular low-grade inflammation, the latter is considered to be a marker of endothelial dysfunction. Because of these properties, one might presume them to be closely interrelated. In this article, we review the available evidence concerning the relationships of CRP and urinary albumin excretion, with each other and with other cardiovascular risk markers might be present in the cardiovascular risk estimation formula of the near future. The reasons that this formula might or should CRP and urinary albumin and the metabolic syndrome are discussed.
引用
收藏
页码:379 / 384
页数:6
相关论文
共 59 条
[51]   Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals:: A 4.4-year follow-up study.: The Nord-Trondelag Health Study (HUNT), Norway [J].
Romundstad, S ;
Holmen, J ;
Kvenild, K ;
Hallan, H ;
Ellekjær, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (03) :466-473
[52]   Mechanism of albuminuria associated with cardiovascular disease and kidney disease [J].
Russo, LM ;
Comper, WD ;
Osicka, TM .
KIDNEY INTERNATIONAL, 2004, 66 :S67-S68
[53]   Cystatin C and the risk of death and cardiovascular events among elderly persons [J].
Shlipak, MG ;
Sarnak, MJ ;
Katz, R ;
Fried, LF ;
Seliger, SL ;
Newman, AB ;
Siscovick, DS ;
Stehman-Breen, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (20) :2049-2060
[54]   C-reactive protein modifies the relationship between blood pressure and microalbuminuria [J].
Stuveling, EM ;
Bakker, SJL ;
Hillege, HL ;
Burgerhof, JGM ;
de Jong, PE ;
Gans, ROB ;
de Zeeuw, D .
HYPERTENSION, 2004, 43 (04) :791-796
[55]   Relationship between effects of statins, aspirin and anglotensin II modulators on high-sensitive C-reactive protein levels [J].
Takeda, T ;
Hoshida, S ;
Nishino, M ;
Tanouchi, J ;
Otsu, K ;
Hori, M .
ATHEROSCLEROSIS, 2003, 169 (01) :155-158
[56]   C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men -: Results from the MONICA Augsburg Cohort Study, 1984-1998 [J].
Thorand, B ;
Löwel, H ;
Schneider, A ;
Kolb, H ;
Meisinger, C ;
Fröhlich, M ;
Koenig, W .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (01) :93-99
[57]   Relationship of C-reactive protein to risk of cardiovascular disease in the elderly - Results from the Cardiovascular Health Study and the Rural Health Promotion Project [J].
Tracy, RP ;
Lemaitre, RN ;
Psaty, BM ;
Ives, DG ;
Evans, RW ;
Cushman, M ;
Meilahn, EN ;
Kuller, LH .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1997, 17 (06) :1121-1127
[58]   Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy:: The LIFE study [J].
Wachtell, K ;
Ibsen, H ;
Olsen, MH ;
Borch-Johnsen, K ;
Lindholm, LH ;
Mogensen, CE ;
Dahlöf, B ;
Devereux, RB ;
Beevers, G ;
de Faire, U ;
Fyhrquist, F ;
Julius, S ;
Kjeldsen, SE ;
Kristianson, K ;
Lederballe-Pedersen, O ;
Nieminen, MS ;
Okin, PM ;
Omvik, P ;
Oparil, S ;
Wedel, H ;
Snapinn, SM ;
Aurup, P .
ANNALS OF INTERNAL MEDICINE, 2003, 139 (11) :901-906
[59]   Prediction of coronary heart disease using risk factor categories [J].
Wilson, PWF ;
D'Agostino, RB ;
Levy, D ;
Belanger, AM ;
Silbershatz, H ;
Kannel, WB .
CIRCULATION, 1998, 97 (18) :1837-1847